ipamorelin coa

Ipamorelin COA: Direct Analytical Overview

An Ipamorelin COA (Certificate of Analysis) is a lot-specific analytical document validating that a batch of synthesized ipamorelin peptide meets strict quantitative purity, identity, and safety standards. Verified through Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS), a compliant COA certifies a purity threshold of ≥99% and confirms the exact molecular mass of 711.85 g/mol.

For research personnel conducting standardized assays, reviewing a comprehensive Ipamorelin certificate of analysis is essential to eliminate batch variability and avoid artifacts caused by truncated peptide sequences, residual salts, or bacterial lipopolysaccharides. PX1 Research provides lot-specific COAs generated by independent ISO 17025 accredited laboratories with every shipment.

Ipamorelin Amino Acid Sequence and Chemical Identification

The primary **ipamorelin amino acid sequence** is a synthetic pentapeptide defined as Aib-His-D-2Nal-D-Phe-Lys-NH2. Unlike endogenously produced peptide hormones, Ipamorelin incorporates unnatural and D-configuration amino acid residues designed to optimize receptor affinity and metabolic stability in experimental models.

Specifically, the sequence includes alpha-aminobutyric acid (Aib) at the N-terminus, followed by L-histidine, D-2-naphthylalanine (D-2Nal), D-phenylalanine (D-Phe), and a C-terminally amidated L-lysine (Lys-NH2). The substitution of D-stereoisomers at positions 3 and 4 directly protects the peptide backbone from rapid enzymatic cleavage by circulating exopeptidases and endopeptidases during preclinical investigations.

Researchers evaluating structural modifications in ghrelin mimetics can cross-reference sequence alignments across our full catalog of research peptides to compare how terminal amidation and non-canonical amino acids influence overall metabolic half-life.

Ipamorelin Peptide Structure and Mass Spectrometry Specifications

Understanding the complete **ipamorelin peptide structure** requires examining both its molecular formula—C38H49N9O5—and its three-dimensional conformation. With a monoisotopic mass of 711.38 Da and a average molecular weight of 711.85 g/mol, Ipamorelin represents one of the smallest and most targeted synthetic growth hormone secretagogues (GHS) available for laboratory study.

On an ESI-MS spectrum generated during analytical testing, the principal molecular ion peak appears at m/z 712.86 [M+H]+. The presence of secondary peaks or significant baseline noise on a mass chromatogram indicates incomplete synthesis, oxidation products, or deamidation, all of which compromise research reproducibility. When reviewing structural data in our peptides research library, researchers can observe how clean mass spectra correlate directly with linear signal responses in ghrelin receptor binding assays.

Standard Components of an Authentic Ipamorelin Certificate of Analysis

A compliant, audit-ready **ipamorelin certificate of analysis** must document multiple physical and chemical parameters beyond simple chromatographic purity. Essential standard metrics include:

1. Purity Profile (RP-HPLC): Quantifies the target peptide peak area relative to total integrated peak areas. Research-grade material must exhibit ≥99.0% purity at 214 nm and 220 nm detection wavelengths. 2. Mass Conformity (MS): Confirms sequence identity by matching observed mass-to-charge ratios with theoretical values. 3. Endotoxin Testing (LAL Assay): Measures bacterial endotoxins (LPS). Limits must remain below <0.1 EU/mg to prevent confounding immune or inflammatory responses in animal tissue models. 4. Net Peptide Content & Moisture (Karl Fischer): Differentiates between actual peptide mass and counter-ions (such as trifluoroacetate or acetate) or residual hydration water. 5. Appearance and Solubility: Verifies physical state as a white, lyophilized cake or powder capable of complete dissolution in sterile aqueous buffers.

Suppliers failing to publish independent, lot-specific testing data introduce significant variables into quantitative research. PX1 Research mandates third-party COAs for every lot, backed by US-based manufacturing and ISO 17025 accredited validation.

Analytical Comparison Criteria for Laboratory Peptide Quality

To ensure institutional reproducibility, laboratory managers should evaluate supplier documentation against strict, non-negotiable verification criteria. The following benchmark standards distinguish research-grade compounds from sub-standard materials:

• Third-Party Testing: Verification conducted by an independent laboratory, not an internal manufacturer report. • HPLC Peak Resolution: Baseline separation of impurity peaks, ensuring zero masked co-eluting contaminants. • Mass Accuracy: Mass deviation under 0.5 Da from the theoretical monoisotopic mass. • Endotoxin Quantification: Absolute quantification using Kinetic Chromogenic LAL methods. • Lot Traceability: Direct matching between vial batch labels, chain of custody documentation, and COA lot numbers. • Domestic Origin & Logistics: Fast dispatch from US-based facilities to mitigate thermal degradation during extended transit. PX1 ships all orders same-day Monday through Friday from fulfillment centers in California and Arizona.

Pharmacological Mechanism and Growth Hormone Pulsatility in Preclinical Models

Ipamorelin acts as a selective agonist at the growth hormone secretagogue receptor (GHSR-1a), mimicking the endogenous ligand ghrelin. In animal studies and in vitro pituitary tissue preparations, Ipamorelin binds GHSR-1a with high nanomolar affinity, initiating an intracellular signaling cascade mediated by phospholipase C and inositol trisphosphate (IP3), leading to transient intracellular calcium mobilization and pulsatile growth hormone (GH) secretion.

A critical distinction of Ipamorelin identified in preclinical literature is its high degree of selectivity. Unlike earlier generation growth hormone secretagogues, Ipamorelin stimulates GH release without triggering significant off-target elevations in plasma cortisol, adrenocorticotropic hormone (ACTH), or prolactin. This narrow pharmacological profile makes it a primary reference compound for dissecting somatotroph signaling without confounding glucocorticoid stress responses.

Comparative Analysis: Ipamorelin vs. GHRP-6, GHRP-2, and CJC-1295

When designing comparative secretagogue trials, investigators frequently evaluate Ipamorelin alongside related compounds in the hexapeptide and GHRH-analogue families. Selecting the appropriate control or co-administered ligand depends on sequence structure and receptor cross-reactivity.

While ghrp-6 and ghrp-2 share GHSR-1a agonism, both compounds induce measurable increases in cortisol and prolactin levels in animal models, with GHRP-6 additionally activating ghrelin receptors in the hypothalamus that stimulate appetite. In contrast, Ipamorelin lacks the orexigenic driving mechanics seen in GHRP-6 studies. When evaluating synergy with growth hormone-releasing hormone (GHRH) analogues, researchers often pair Ipamorelin with cjc-1295-without-dac or sermorelin. This dual-activation approach targets distinct receptor pathways (GHSR-1a and GHRH-R, respectively), resulting in amplified, physiological GH release patterns in vitro.

Laboratory Reconstitution Protocols and Solvent Compatibility

Reconstitution of lyophilized Ipamorelin must be performed under sterile laboratory conditions using appropriate aqueous media. For standard biochemical assays, Bacteriostatic Water (0.9% benzyl alcohol) or sterile Phosphate-Buffered Saline (PBS, pH 7.4) is recommended.

To reconstitute a standard 2 mg or 5 mg vial, introduce the chosen solvent along the inner glass wall of the vial rather than forcing liquid directly onto the lyophilized cake. Allow the vial to sit at room temperature for 5–10 minutes, followed by gentle swirling. Avoid mechanical agitation, vortexing, or vigorous shaking, as shearing forces can alter the secondary peptide structure and induce aggregation. Reconstituted stock solutions should be aliquoted into single-use polypropylene microtubes to avoid repeated freeze-thaw cycles.

Storage Requirements, Stability, and Thermal Sensitivity

Lyophilized Ipamorelin powder exhibits robust stability when stored at -20°C in a desiccated environment, shielded from direct light exposure. Under these conditions, the peptide maintains structural integrity and analytical purity for up to 24 months as confirmed by follow-up HPLC testing.

Following reconstitution, liquid aliquots are stable at 2°C to 8°C for short-term experimental periods (up to 30 days when reconstituted with bacteriostatic agents). For long-term preservation of aqueous stock solutions, store aliquots at -80°C. Degradation pathways primarily include peptide bond hydrolysis at elevated temperatures or oxidation of the histidine side chain upon prolonged exposure to dissolved oxygen. Utilizing proper storage parameters ensures that experimental outcomes remain consistent with data documented on the original ipamorelin coa.

Procurement and Institutional Supply via PX1 Research

PX1 Research is an established American supplier dedicated to providing research institutions, university laboratories, and contract research organizations (CROs) with ultra-pure research compounds. Every batch of Ipamorelin undergoes strict quality assurance protocols inside US-based, GMP-compliant facilities.

Principal investigators and laboratory managers requiring high-volume supplies or specialized batch documentation can establish a wholesale research account to access bulk pricing schedules, dedicated account management, and direct access to raw analytical raw data files. Orders placed before daily cut-off times ship same-day from our dual distribution centers in California and Arizona.